The Journal of Immunology, Vol 133, Issue 1 440-447, Copyright © 1984 by American Association of Immunologists

ARTICLES

Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis

CL Jaffe, E Bennett, G Grimaldi Jr and D McMahon-Pratt

Sixteen species-specific monoclonal antibodies were produced against membranes of Leishmania donovani. These antibodies only reacted with determinants present on L. donovani. No cross-reactions were found with any other species of Leishmania or with membranes of Trypanosoma cruzi. An extensive analysis of the binding specificities of selected antibodies was carried out by using whole promastigote homogenates as antigen. Monoclonal antibodies D-1, D-2, D-3, and D-4 correctly identified all 44 L. donovani stocks from a cross-panel of 84 New and Old World Leishmania stocks. Antibodies D-1 and D-2 were also useful for species classification by immunofluorescence. No cross-reactions were observed with any other Leishmania species examined. Based on either Western blot and/or radioimmunoprecipitation analyses, five distinct groups of molecules associated with L. donovani-specific antigenic determinants were identified. These molecules range in m.w. from 18 to 84 kilodaltons. The antigenic molecules recognized by antibodies D-2, D-10, and D-13 are also recognized by antibodies present in sera from patients with visceral leishmaniasis (kala-azar). Kala-azar sera obtained from cases in both the Old and New World specifically compete with these monoclonal antibodies for the appropriate antigenic determinants in Western blot analysis. These monoclonal antibodies and/or the purified protein antigens may be useful in the development of a serologic assay for the clinical diagnosis of visceral leishmaniasis caused by L. donovani and in epidemiologic studies of leishmaniasis.

This article has been cited by other articles:

				G. Bomfim, B. B. Andrade, S. Santos, J. Clarencio, M. Barral-Netto, and A. Barral Cellular Analysis of Cutaneous Leishmaniasis Lymphadenopathy: Insights into the Early Phases of Human Disease Am J Trop Med Hyg, November 1, 2007; 77(5): 854 - 859. [Abstract] [Full Text] [PDF]

				G. Sreenivas, B. V. Subba Raju, R. Singh, A. Selvapandiyan, R. Duncan, D. Sarkar, H. L. Nakhasi, and P. Salotra DNA Polymorphism Assay Distinguishes Isolates of Leishmania donovani That Cause Kala-Azar from Those That Cause Post-Kala-Azar Dermal Leishmaniasis in Humans J. Clin. Microbiol., April 1, 2004; 42(4): 1739 - 1741. [Abstract] [Full Text] [PDF]

				P Salotra, G Sreenivas, K R Beena, A Mukherjee, and V Ramesh Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods J. Clin. Pathol., November 1, 2003; 56(11): 840 - 843. [Abstract] [Full Text] [PDF]

				M. Chatterjee, C. L. Jaffe, S. Sundar, D. Basu, S. Sen, and C. Mandal Diagnostic and Prognostic Potential of a Competitive Enzyme-Linked Immunosorbent Assay for Leishmaniasis in India Clin. Vaccine Immunol., July 1, 1999; 6(4): 550 - 554. [Abstract] [Full Text] [PDF]

				D. Wirth, W. Rogers, R Barker Jr, H Dourado, L Suesebang, and B Albuquerque Leishmaniasis and malaria: new tools for epidemiologic analysis Science, November 21, 1986; 234(4779): 975 - 979. [Abstract] [PDF]